/sci/ - Science & Math

DEFEROXAMINE CURES CANCER

> High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines
https://pubmed.ncbi.nlm.nih.gov/29562821/
> An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells

> Fryknäs, M., Zhang, X., Bremberg, U. et al. Iron chelators target both proliferating and quiescent cancer cells. Sci Rep 6, 38343 (2016).
https://doi.org/10.1038/srep38343
> Deferoxamine Inhibition of Human Neuroblastoma Viability and Proliferation
https://aacrjournals.org/cancerres/article/48/24_Part_1/7189/493542/Deferoxamine-Inhibition-of-Human-Neuroblastoma
> Deferoxamine Counteracts Cisplatin Resistance in A549 Lung Adenocarcinoma Cells by Increasing Vulnerability to Glutamine Deprivation-Induced Cell Death
https://www.frontiersin.org/articles/10.3389/fonc.2021.794735/full
> Deferoxamine Increases Breast Cancer Radiosensitivity

> Iron chelating agent, deferoxamine, induced apoptosis in Saos-2 osteosarcoma cancer cells
https://www.e-cep.org/journal/view.php?number=2009520212
> A Case of Positive Tumor Marker Response after Intra-arterial Deferoxamine Infusion Therapy in a Hepatocellular Carcinoma Patient with Decompensated Liver Function
https://www.e-jlc.org/journal/view.php?doi=10.17998/jlc.14.2.127

Intranasal deferoxamine targets the brain primarily and suppresses inflammation improving central insulin sensitivity and this has downstream effects within the periphery by improving insulin sensitivity, insulin transport to the brain as well as supporting the function of our hypothalamus.
> Stimulation of hypothalamic oxytocin neurons suppresses colorectal cancer progression in mice

DEFEROXAMINE CURES CANCER

> High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines
https://pubmed.ncbi.nlm.nih.gov/29562821/
> An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells

> Fryknäs, M., Zhang, X., Bremberg, U. et al. Iron chelators target both proliferating and quiescent cancer cells. Sci Rep 6, 38343 (2016).
https://doi.org/10.1038/srep38343
> Deferoxamine Inhibition of Human Neuroblastoma Viability and Proliferation
https://aacrjournals.org/cancerres/article/48/24_Part_1/7189/493542/Deferoxamine-Inhibition-of-Human-Neuroblastoma
> Deferoxamine Counteracts Cisplatin Resistance in A549 Lung Adenocarcinoma Cells by Increasing Vulnerability to Glutamine Deprivation-Induced Cell Death
https://www.frontiersin.org/articles/10.3389/fonc.2021.794735/full
> Deferoxamine Increases Breast Cancer Radiosensitivity

> Iron chelating agent, deferoxamine, induced apoptosis in Saos-2 osteosarcoma cancer cells
https://www.e-cep.org/journal/view.php?number=2009520212
> A Case of Positive Tumor Marker Response after Intra-arterial Deferoxamine Infusion Therapy in a Hepatocellular Carcinoma Patient with Decompensated Liver Function
https://www.e-jlc.org/journal/view.php?doi=10.17998/jlc.14.2.127

Intranasal deferoxamine targets the brain primarily and suppresses inflammation improving central insulin sensitivity and this has downstream effects within the periphery by improving insulin sensitivity, insulin transport to the brain as well as supporting the function of our hypothalamus.
> Stimulation of hypothalamic oxytocin neurons suppresses colorectal cancer progression in mice

ever since I've started snorting deferoxamine, I've developed sarcoma.
The doctors say I have 5 months left
What should I do, /sci/bros?

Would hydroxychloroquine injections help? /pol/ told me it could